Massularia acuminata is a West African tree used for tooth cleaning and marketed as an oral extract for male hormone and sexual support. Human trials test only children's chewing sticks, with conflicted gum results matching toothbrushing. Oral benefits rest on rodent and cell studies, which also show liver, kidney, heart, and testicular damage from prolonged or high doses, requiring strict dose limits, short cycles, and blood monitoring. (Full Review)
| Marker | Target | Why |
|---|---|---|
| Serum Total Testosterone (males) | 264–916 ng/dL (standard reference range) | Expected-change and safety marker: tracks androgenic response or high-dose suppression. |
| Luteinizing Hormone (LH) & Follicle-Stimulating Hormone (FSH) | LH: 1.7–8.6 mIU/mL; FSH: 1.5–12.4 mIU/mL (standard reference range) | Expected-change and safety marker: monitors pituitary stimulation versus chronic suppression. |
| Alanine Aminotransferase (ALT), Aspartate Aminotransferase (AST) & Total Bilirubin | ALT: 7–56 U/L; AST: 8–33 U/L; Bilirubin: 0.1–1.2 mg/dL (standard reference range) | Safety check: detects preclinical hepatocyte injury or biliary stress; elevation halts use. |
| Serum Creatinine & Blood Urea Nitrogen (BUN) | Creatinine: 0.7–1.3 mg/dL; BUN: 7–20 mg/dL (standard reference range) | Safety check: detects glomerular or tubular nephrotoxicity; elevation above baseline halts use. |
| Glycated Hemoglobin (HbA1c) | 4.0%–5.6% (standard reference range) | Expected-change marker: tracks glycemic modulation observed in diabetic rodent models. |
Cadence: Baseline morning fasting draw before initiation; repeat hepatic and renal safety panels at 2–3 weeks (cycle completion), hormone and glycemic markers at 3–4 weeks (8–12 weeks for HbA1c), and every 3–6 months across repeated cycles.